Vabysmo (faricimab-svoa)

1,521.81

Vabysmo (faricimab-svoa) is a prescription medicine that is used to treat two leading causes of vision loss: neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME).

DISEASE INDICATIONS

Macular Degeneration

MANUFACTURER

Roche Registration Limited

USAGE

Intravitreal

MEDICINE APPROVED BY

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

    WE CAN HELP WITH YOUR IMPORT DOCUMENTS

    We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
VABYSMO (FARICIMAB-SVOA) Package Single-dose vial

One vial of 120 mg/mL

Reviews

There are no reviews yet.

Be the first to review “Vabysmo (faricimab-svoa)”

Your email address will not be published. Required fields are marked *

Shopping Cart